비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Dizman N et al., Genomic profiling in renal cell carcinoma, Nat Rev Nephrol, 2020

Ghoreifi A et al., Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review, JAMA Oncol, 2024

NCCN guidelines Version 1. 2024 Kidney Cancer, 2024

Rathmell WK et al., Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline, J Clin Oncol, 2022

Shapiro DD et al., Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals, Eur Urol Open Sci, 2023

Bakouny Z et al., Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium, Eur Urol, 2023

Chen B et al., The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis, Int J Surg, 2023

Fransen van de Putte EE et al., Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease? Eur Urol Open Sci, 2023